Reserpine is an alkaloid compound derived from the plant Rauwolfia serpentina that depletes monoamine neurotransmitters, including serotonin, norepinephrine, and dopamine, from neuronal storage vesicles. Originally used as an antihypertensive and antipsychotic medication, reserpine has become an important pharmacolo…
Reserpine is an alkaloid compound derived from the plant Rauwolfia serpentina that depletes monoamine neurotransmitters, including serotonin, norepinephrine, and dopamine, from neuronal storage vesicles. Originally used as an antihypertensive and antipsychotic medication, reserpine has become an important pharmacological tool in neuroscience research, particularly for inducing depression-like states in experimental models. Research published in Advanced Pharmaceutical Science And Technology has employed reserpine in preclinical studies examining novel neuroprotective compounds. Specifically, the journal has documented experimental work using reserpine-induced depression models to evaluate the antidepressant-like activity of new tetrapeptide neuroprotectors, including compounds homologous to specific adrenocorticotropic hormone sequences. This application of reserpine is significant because it allows researchers to systematically assess the therapeutic potential of candidate neuropsychiatric drugs by creating reproducible neurochemical deficits that mimic aspects of clinical depression. Understanding reserpine's mechanism and experimental applications remains relevant for pharmaceutical scientists developing and testing new treatments for mood disorders and other conditions involving monoaminergic neurotransmission dysfunction.
1 peer-reviewed article, ranked by relevance. Each links to its DOI.
The 1 article above has been cited 2 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.
A sample of recent works citing this journal's research on Reserpine, linking to each citing work.